Clinical Trials Browser

Phase 4 × Completed × Rivaroxaban × Clear all

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Phase 4 Completed

Hemorrhage, Recurrence

NCT01708850 2016-09-08

Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)

Phase 4 Completed

Neoplasms, Upper Extremity Deep Vein Thrombosis